Navigation Links
Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
Date:8/9/2012

ockholders The $1.3 million and $7.2 million increase in net loss for the three and six months ended June 30, 2012, respectively, compared with the same periods in 2011, resulted primarily from a significant (non-cash) change in fair value of common stock warrants, based on a required quarterly mark to market adjustment to reflect changes in the Company's stock price, and a decrease in grant revenue.

Capital Resources As of June 30, 2012, cash and cash equivalents plus short-term investments in certificates of deposit, mutual funds, and municipal bonds were $19.5 million compared with $30.3 million as of December 31, 2011.

Based on management's projections and analysis, the Company believes that current cash and cash equivalents plus short-term investments are sufficient to meet its planned working capital requirements into the third quarter of 2013.

During the quarter, Inovio replaced a prior ATM agreement that the Company already had in place with a sales agreement with Cowen and Company, LLC, under which Inovio may from time to time offer and sell common stock with aggregate proceeds of up to $25 million. Inovio may sell its stock through Cowen by methods deemed to be an "at the market" offering (ATM), including sales made through the NYSE MKT or any other existing trading market for the common stock or to or through a market maker.

Inovio's balance sheet and statement of operations are provided below. Form 10-Q providing the complete 2012 second quarter financial report can be found at: http://ir.inovio.com/secfilings.

Corporate UpdateClinical DevelopmentDuring the second quarter, Inovio reported that its SynCon® avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.

Subsequent to the quarte
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
2. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
3. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
4. Inovio Pharmaceuticals to Present at JMP Investor Conference
5. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
6. Inovio Pharmaceuticals to Present at SPI 2012
7. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
8. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
9. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
10. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
11. Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketing (CLM) Strategies Drives Sales Force Efficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  An international roster ... Saturday, May 18, in Santa Monica, Calif. ... new lung-sparing therapies for MPM, a rare form of ... affects the pleura, the lining of the chest. ... and Blood Institute, the 3rd Annual International Symposium on ...
(Date:5/24/2013)... 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), ... today that Dr. Robert Grieve , the ... Napolitano , executive vice president and chief financial officer, ... is being held May 30, 2013 in New ... The Company,s presentation is scheduled to begin at ...
(Date:5/24/2013)... 2013 China Biologic Products, Inc. (Nasdaq: CBPO, ... plasma-based biopharmaceutical company in China , ... a public announcement issued by Shanghai RAAS Blood Products ... Shenzhen Stock Exchange, that on May 21, 2013, Ms. ... one of the shareholders of the Company, and her ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4
(Date:5/24/2013)... National Geographic questioned in an article on ... remembrance is getting lost in the swirl of summer kickoff. ... prompted some research and analysis on the subject based on ... statistical evaluation of around 180 ecards shared by Americans, suggests ... emotions of fun and celebration. In the modern era ...
(Date:5/24/2013)... 2013 MonaVie announces the appointment of Mauricio ... member of the Ethics Board of ABEVD (Brazilian Association of ... elected to this council and will do my best to ... industry,” says Patrocinio. , The direct selling industry is booming ... The direct selling industry has, for decades, helped improve the ...
(Date:5/24/2013)... This report “EpiCast Report: Meningococcal Disease - Epidemiology ... factors and global trends for meningococcal disease in eight ... Australia, and Brazil). It includes a 10-year epidemiological forecast ... (<1, 1–4, 5–14, 15–24, 25–44, 45–64, and =65 years) ... markets. The other serogroups, namely serogroups A and X, ...
(Date:5/24/2013)... 2013 According to the new market ... Forecasts (2011 - 2016)” published by MarketsandMarkets, global micro ... by the end of year 2010 and is expected ... CAGR of 17.9% from 2011 to 2016. , Browse:, ... 44 Figures , 370 pages ...
(Date:5/24/2013)... Just about any bodyweight training program includes a ... based in Dallas, GA that uses a variety of bodyweight ... is not used enough. , “The medicine ball pushup ... more challenging. By keeping your hands on a medicine ball, ... being worked much harder than a standard pushup. This unique ...
Breaking Medicine News(10 mins):Health News:Is Memorial Day More Than A Three-Day Weekend 2Health News:MonaVie Brazil Executive Elected to Ethics Board of ABEVD 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2
... study conducted by researchers say it is a misconception ... older or housebound people.// ,Researchers examined 150 ... levels of vitamin D. Among the participants, all African-American, ... D deficiencies, as were all patients younger than 30. ...
... A pitch-black room may be the healthiest environment for your ... at night // may put children at risk for ... to disrupt the circadian rhythm and suppress the production of ... been shown to protect DNA from oxidative damage. Once damaged, ...
... study shows sinusitis in asthma patients tends to be ... suggest patients // can have dramatic improvement in symptoms ... is used. ,In the study patients with asthma ... polyps, olfactory dysfunction, and nasal congestion compared to patients ...
... new study shows moderate consumption of alcohol may cut ... arteries.// Researchers evaluated 225 men after they had undergone ... open blocked arteries with a stent. Less traumatic than ... cause inflammation resulting in renarrowing of the artery, usually ...
... study researchers say the antidepressant duloxetine, also known ... fibromyalgia in women . Duloxetine works by stopping ... of the brain’s neurotransmitters that are linked to ... that is characterized by body pain, muscle tenderness, ...
... cluster of risk factors known as metabolic syndrome is ... risk factors. // ,Metabolic syndrome has been ... coronary heart disease. Metabolic syndrome includes looking at factors ... has two different definitions including one by the National ...
Cached Medicine News:
Pre-expanded for convenience; no need to pre-soak and fan. Lint-free PVAmaterial...
Used after ablation to wash away particulate from anterior & posterior sides of flap & stromal bed. Conforms to the corneal flap. .0mm extension with a 11.0mm radius, Angled tip....
30, 6.0mm from end...
Smaller diameter wire probes & olive shape tips provide easier insertion through the lacrimal sac, 35cm (14 in) long, ID- .30mm (.012in); OD- .64mm (.025 in). S.S. Probes: .40mm x 11cm (27 G x 4 1/4...
Medicine Products: